Broadcast

DanGer Shock RCT: A Decade of Data

Andreas Goetzenich, Jacob E Møller, Christian Schulze , et al

Watch time: 1h 1m 37s

Broadcast

Evidence-Based Criteria for Transcatheter Tricuspid Valve Replacement

Volker Rudolph, Sam Dawkins, Ali Vazir, et al

Watch time: 1h 1m 24s

Broadcast

Evolving Strategies in Pulmonary Embolism: From Risk Stratification to…

Stavros Konstantinides, Sylwia Sławek-Szmyt, José M Montero-Cabezas, et al

Watch time: 1h 8m 28s

Broadcast

TAVI in Small Aortic Anatomy: Optimising Planning and Outcomes

Yohei Ohno, Andrew Cook, Mehdi Eskandari, et al

Watch time: 1h 16m 40s

Michael J Mack

Watch time: 2h 44m 15s (17 videos)

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Articles

Drug-eluting Stent Utilisation and Outcomes in Acute Coronary Syndromes – Evidence-based Practice Without the Evidence?

Citation:

Interventional Cardiology 2006;1(1):33–4

BioMime Sirolimus-eluting Coronary Stent System

Citation:

Interventional Cardiology 2011;6(1):39–43

Impact of Bleeding and Transfusion in Acute Coronary Syndromes and Percutaneous Coronary Interventions

Citation:

Interventional Cardiology 2008;3(1):85-8

Initial Clinical Experience with a Novel Dedicated Cobalt-Chromium Stent for the Treatment of Below-the-knee Arterial Disease

Citation:

Interventional Cardiology 2008;3(1):69-72